Italian consensus on EULAR recommendations 2005 for the management of hip osteoarthritis;Consensus italiana sulle raccomandazioni EULAR 2005 per il trattamento dell'artrosi dell'anca

Reumatismo

Volumn 58, Issue 4, 2006, Pages 301-309

  Punzi, Leonardo ^a   Doherty, M ^b   Zhang, W ^b   Cimmino, M A ^c   Carrabba, M ^d   Frizziero, L ^e   Grassi, W ^f   Lapadula, G ^g   Modena, V ^h   Arioli, G ⁱ   Brignoli, O ^j   Canesi, B ^k   Cazzola, M ^l   Cricelli, C ^m   Faldini, A ⁿ   Fioravanti, A ^o   Gimigliano, R ^q   Giustini, A ^p   Iannone, F ^g   Leardini, G ^r   Meliconi, R ^s   Molfetta, L ^c   Patrignani, P ^t   Parente, L ^u   Ramonda, R ^a   Randelli, G ^v   Salaffi, F ^f   Spadaro, A ^w   Bombardieri, S ⁿ   more..

^a UNIVERSITY OF PADOVA   (Italy)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e MAGGIORE HOSPITAL   (Italy)

^f UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^g UNIVERSITY OF BARI   (Italy)

^h MOLINETTE HOSPITAL   (Italy)

ⁱ CARLO POMA HOSPITAL   (Italy)

^j Società Italiana di Medicina Generale   (Italy)

^k FATEBENEFRATELLI HOSPITAL   (Italy)

^l Azienda Ospedaliera Busto Arsizio   (Italy)

^m Societa Italiana di Medicina Generale   (Italy)

ⁿ UNIVERSITY OF PISA   (Italy)

^o UNIVERSITY OF SIENA   (Italy)

^p IRCCS   (Italy)

^q UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^r Az Osp   (Italy)

^s UNIVERSITY OF BOLOGNA   (Italy)

^t UNIVERSITY OF CHIETI   (Italy)

^u UNIVERSITY OF SALERNO   (Italy)

^v ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^w SAPIENZA UNIVERSITY OF ROME   (Italy)

more..

Author keywords

Osteoarthritis; Osteoarthritis of the hip; Recommendations for osteoarthritis; Treatment of osteoarthritis

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

CONFERENCE PAPER; CONSENSUS; EXPERIENCE; HIP OSTEOARTHRITIS; HUMAN; INFORMATION DISSEMINATION; MEDICAL SOCIETY; MEDICAL SPECIALIST; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; CONSENSUS DEVELOPMENT; EUROPEAN UNION; ITALY; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE;

EUROPEAN UNION; HUMANS; ITALY; OSTEOARTHRITIS, HIP; PRACTICE GUIDELINES; PRIMARY HEALTH CARE; SOCIETIES, MEDICAL;

EID: 34247142373     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Yelin E, Callahan LF, for the National Arthritis Data Work Group. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995; 38: 1351-62.
2. Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 1988; 10: 1-28.
3. Tepper S, Hochberg MC. Factors associated with hip osteoarthritis: data from the First National Health and Nutrition Examination Survey (NHANES-I). Am J Epidemiol 1993; 137: 1081-8.
4. Mannoni A, Briganti MP, Di Bari M, Ferrucci L, Costanzo S, Serni U, et al. Epidemiological profile of symptomatic osteoarthritis in older adults: a population based study in Dicomano, Italy. Ann Rheum Dis 2003; 62: 576-8.
5. Salaffi F, De Angelis R, Grassi W. MArche Pain Prevalence INvestigation Group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005; 23: 819-28.
6. Cimmino MA, Sarzi-Puttini P, Scarpa R, Caporali R, Parazzini F, Zaninelli A, et al. Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA study. Semin Arthritis Rheum 2005; 35 (1 Suppl 1): 17-23.
7. Punzi L, Ramonda R. Importance of self-reported health-related quality of life in identifying the needs of elderly people with osteoarthritis. Aging Clin Exp Res 2005; 17: 253-4.
8. Salaffi F, Carotti M, Stancati A, Grassi W. Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. Aging Clin Exp Res 2005; 17: 253-4.
9. Leardini G, Mascia MT, Stisi S, Sandri G, Franceschini M. Sanitary costs of osteoarthritis. Reumatismo 2001; 53: 316-322.
10. Corti M-C, Rigon C. Epidemiology of osteoarthritis: prevalence, risk factors and functional impact. Aging Clin Exp Res 2003; 15: 359-63.
11. Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JW, et al. EULAR recommendations for the management of osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000; 59: 936-44.
12. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR Recommendations 2003: an evidence based medicine approach to the management of knee osteoarthritis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62: 1145-55.
13. Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, et al. EULAR evidence based recommendations for the management of hip osteoarthritis - report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 2005; 64: 5: 669-681.
14. Dougados M, Betteridge N, Burmester GR, Euller-Ziegler L, Guillemin F, Hirvonen J, et al. EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 2004; 63: 1172-6.
15. Punzi L, Canesi B, Carrabba M, Cimmino MA, Frizziero L, Lapadula G, et al. Consensus italiana sulle raccomandazioni EULAR 2003 per il trattamento della gonartrosi. Reumatismo 2004; 56: 190-201.
16. Woolf AD, Zeidler H, Haglund U, Carr AJ, Chaussade S, Cucinotta D, et al. Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries. Ann Rheum Dis 2004; 63: 342-7.
17. Pincus T, Koch G, Lei H, Mangal B, Sokka T, Moskowitz R, et al. Patient preference for placebo, acetaminophen or celecoxib efficacy studies (PACES): two randomised placebo-controlled cross-over clinical trias in patients with osteoarthritis of the knee or hip. Ann Rheum Dis 2004; 63: 931-9.
18. Pincus T, Wang X, Chung C, Sokka T, Koch GG. Patient preference in a crossover clinical trial of patients with osteoarthritis of the knee or hip: face validity of self-report questionnaire ratings. J Rheumatol. 2005; 32: 533-9.
19. Wegman A, van der Windt D, van Tulder M, Stalman W, de Vries T. Nonsteroidal antiinflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines. J Rheumatol 2004: 31: 344-54.
20. Towheed T, Shea B, Wells G, Hochberg M. Analgesia and non-aspirin, non steroidal anti-inflammatory drugs for osteoarthritis of the hip. Cochrane Database Syst Rev 2000; 2: CD000517.
21. Lewis SC, Longman MJS, La porte J-R, Matthres NS, Rawlins MD, Wilhom B-E. Dose-response relatiosnhips between individual nonaspirim nonsteroidal anti-inflammatory drugs (NSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patients data. Br J Clin Pharmacol 2002; 54: 320-6.
22. Leandro G, Pilotto A, Franceschi M, Bertin T, Lichino E, Di Mario F. Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trias. Dig Dis Sci 2001; 46: 1924-36.
23. Deeks JJ, Smith LA, Bradley MD. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. BMJ 2002; 325: 619-23.
24. FDA issues public health advisory on Vioxx as its manufacturer voluntarily withdraws the product. FDA News. 2004 Sep 30. http://www.fda.gov/ bbs/topics/news/2004/new01122.html
25. Konstam MA, Weir MR, Reicin A, Shapiro D, Sperling RS, Barr E, et al. Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation 2001; 104: 2280-8.
26. Gatti D, Adami S, Canesi B, Cimmino MA, Della Casa O, Del Tacca M, et al. Terapia antinfiammatoria e rischio cardiovascolare. Cosa fare? Reumatismo. 2006; 58: 85-93.
27. Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis. Arch Intern Med 2003; 163: 1514-22.